Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06078371
Other study ID # STUDY00149431
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2023
Est. completion date October 2024

Study information

Verified date October 2023
Source University of Kansas Medical Center
Contact Archie Heddings, MD
Phone 913-588-6164
Email aheddings@kumc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Analgesic drug study that will compare pain outcomes of opioid analgesia and opioid-free analgesia in post-operative orthopedic patients.


Description:

This will be a single center randomized trial. The study will be conducted using block randomization, with two six-month blocks of patient enrollment. The first block will consist of patients undergoing treatment of the above-mentioned fractures with normal standard of care pain management protocol (pre-, intra-, and postoperatively). The second block will consist of patients undergoing treatment the same fractures with opioid-free pain management protocol (pre-, intra-, and postoperatively). Block selection will be determined based on the date of the surgery. However, patients initially assigned to the opioid-free protocol that have CKD/laboratory evidence of poor renal function (ie, elevated BUN/Creatinine) or laboratory evidence of liver function issues (ie, cirrhosis, hypoalbuminemia, elevated liver transaminases, elevated GGT) will crossover to the opioid group as NSAID use and acetaminophen use, respectively, are contraindicated. The use of block randomization will preclude the need for the study coordinator to perform any sort of individual randomization or sealed envelope use for treatment assignment. For subjects who meet eligibility criteria, study informed consent will be obtained at the same time as surgical consent. Those in the standard of care study block will undergo KUMC's normal pain management strategy. Those in the opioid-free study block will receive the same pain-management drugs as the opioid group aside from recieving opioids; all other medical care will be standard in this group. Postoperative weightbearing, immobilization, perioperative antibiotics, drain usage, and discharge criteria will be determined by institutional protocols and will remain the same for each block. All patients will be started on postoperative chemical anticoagulation prophylaxis as determined by their fracture pattern and medical comorbidities. Patients will be clinically monitored for signs of venous thromboembolism and appropriate diagnostic screening will be utilized as necessary. Wound complications will be monitored by the treating surgeon and managed as necessary. We also plan to record patient specific factors including age, sex, BMI, smoking status, comorbidities, and operative time. These variables will be analyzed independently to detect any correlation with the two pain management protocols.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 250
Est. completion date October 2024
Est. primary completion date October 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients (over the age of 18 years old) who undergo surgical treatment for the injuries of interest (stated elsewhere) by an Orthopedic Traumatology Attending Physician at the University of Kansas Hospital will be identified and offered the opportunity to participate in the study. Exclusion Criteria: - i. Patients that are unable to provide informed consent due to sustaining a head injury or incoherence from narcotics given to them post-injury ii. Chronic opioid use iii. Under the age of 18 years old iv. Undergoing revision surgery v. Did not undergo surgical fixation vi. Pregnant/nursing women vii. Vulnerable populations as defined by the University of Kansas Medical Center IRB viii. Did not experience one of the following fractures listed in D.1. above. ix. Patients with CKD and/or cirrhosis will be excluded from the opioid-free pain block (block 2) and will only qualify for the standard of care opioid group (Block 1)

Study Design


Intervention

Other:
Opioid-free pain treatment
Pain treatment includes any medications up to the medical team's discretion aside from opioids.

Locations

Country Name City State
United States The University of Kansas Medical Center Kansas City Kansas

Sponsors (1)

Lead Sponsor Collaborator
University of Kansas Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Numerical Rating Scale (NRS) Pain Scores Patients will be asked how much pain they are experiencing on a 1-10 scale after their surgery. From post surgery up until 6 months post surgery
Secondary Postoperative complications Data will be collected on the presence or absence of various complications due to surgery that include: acute kidney injury, subsequent reoperation, amputation, compartment syndrome, surgical site infection, wound dehiscence, nonunion, or venous thromboembolism. From post surgery up until 6 months post surgery
Secondary Medication usage (timing) The duration of which analgesia is used to treat post-surgical pain will be measured From post surgery up until 6 months post surgery
Secondary Medication usage (quantity) The dosage of analgesia used to treat post-surgical pain will be measured From post surgery up until 6 months post surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05505604 - PENG vs FICB for Hip Fracture in ED Patients N/A
Recruiting NCT04462172 - A Prospective Multicenter Cohort Study About Internal Fixation Using FNS Versus MCS for Femoral Neck Fracture N/A
Enrolling by invitation NCT04110639 - Intraoperative Monitoring of Femoral Head Perfusion N/A
Terminated NCT01908751 - Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2) Phase 3
Recruiting NCT01934049 - Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty Phase 4
Recruiting NCT01219088 - Intrathecal Morphine,Femoral Nerve Block,Periarticular Bupivacaine Infiltration for Pain After Intramedullary Hip Screw Phase 4
Not yet recruiting NCT00749710 - Blood Loss and Complications of Internal Fixation of Femoral Neck Fractures in Patients Treated With Clopidogrel N/A
Active, not recruiting NCT00491673 - A Prospective Randomized Trial of Uncemented Versus Cemented Hemiarthroplasty for Displaced Femoral Neck Fractures N/A
Completed NCT00464230 - Hemiarthroplasty or Internal Fixation for Displaced Femoral Neck Fractures Phase 4
Recruiting NCT03966716 - Hips Screws or (Total) Hip Replacement for Undisplaced Femoral Neck Fractures in Elderly Patients (HipSTHeR) N/A
Recruiting NCT05227924 - Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
Completed NCT03666637 - Femoral Neck Fracture in Adult and Avascular Necrosis and Nonunion
Terminated NCT03721835 - Safety Study of Femoral Neck Fracture System N/A
Not yet recruiting NCT04408053 - Mini-invasive Preventive Fixation of the Contralateral Femoral Neck in Patients Operated on for a Femoral Neck Fracture Phase 3
Recruiting NCT04577261 - FNS (FEMORAL NECK SYSTEM) Study
Recruiting NCT04589598 - Femoral Neck System and Multiple Cannulated Screws in Femoral Neck Fracture N/A
Withdrawn NCT02198820 - Practice Survey on Femoral Neck Fractures and the Incidence of Type of Anesthesia on Patient Outcome N/A
Active, not recruiting NCT02246335 - Hemiarthroplasty Compared to Total Hip Arthroplasty for Displaced Femoral Neck Fractures in the Elderly-elderly N/A
Not yet recruiting NCT00926666 - A Dose Finding Study for Pain Relief of a Broken Hip Phase 4
Withdrawn NCT00317837 - Bipolar Versus Unipolar Hemiarthroplasty for Patients With a Hip Fracture N/A